Search Results

There are 3006189 results for: content related to: Antidepressants and the developing nervous system

  1. Pharmacovigilance-Related Topics at the Level of the International Conference on Harmonisation

    Mann's Pharmacovigilance

    Elizabeth B. Andrews, Nicholas Moore, Pages: 47–62, 2014

    Published Online : 4 APR 2014, DOI: 10.1002/9781118820186.ch5

  2. Regulatory Review: Clinical to Market Transition

    Handbook of Therapeutic Antibodies

    Stefan Dübel, Janice M. Reichert, Pages: 1263–1282, 2014

    Published Online : 12 AUG 2014, DOI: 10.1002/9783527682423.ch42

  3. Globalization of Pediatric Clinical Trials with a Focus on Emerging Countries

    Pediatric Drug Development: Concepts and Applications

    Andrew E. Mulberg, Dianne Murphy, Julia Dunne, Lisa L. Mathis, Pages: 482–513, 2013

    Published Online : 31 JUL 2013, DOI: 10.1002/9781118312087.ch39

  4. Regulatory Activities Associated with Production and Commercialization of Plasma Protein Therapeutics

    Production of Plasma Proteins for Therapeutic Use

    Nancy Kirschbaum, Timothy Lee, Pages: 403–411, 2012

    Published Online : 14 DEC 2012, DOI: 10.1002/9781118356807.ch29

  5. Asia Pacific: China

    Nonclinical Safety Assessment: A Guide to International Pharmaceutical Regulations

    Lijie Fu, Qingli Wang, Pages: 117–134, 2013

    Published Online : 10 MAR 2013, DOI: 10.1002/9781118517000.ch8

  6. Terminologies in Pharmacovigilance

    Mann's Pharmacovigilance

    Elliot Brown, Daniel von Sydow, Pages: 77–93, 2014

    Published Online : 4 APR 2014, DOI: 10.1002/9781118820186.ch7

  7. Cardiovascular toxicity, especially QT/QTc prolongation

    Statistical Methods for Evaluating Safety in Medical Product Development

    Arne Ring, Robert Schall, Pages: 193–228, 2014

    Published Online : 12 DEC 2014, DOI: 10.1002/9781118763070.ch8

  8. Drug Development: General Aspects

    Global New Drug Development: An Introduction

    Jan A. Rosier, Mark A. Martens, Josse R. Thomas, Pages: 23–90, 2014

    Published Online : 18 JUL 2014, DOI: 10.1002/9781118414873.ch3

  9. Genetic Toxicology

    Pharmaceutical Toxicology in Practice: A Guide for Non-Clinical Development

    Peggy Guzzie-Peck, Jennifer C. Sasaki, Sandy K. Weiner, Pages: 139–164, 2011

    Published Online : 13 MAY 2011, DOI: 10.1002/9780470909911.ch8

  10. Analytical Validation within the Pharmaceutical Lifecycle

    Method Validation in Pharmaceutical Analysis: A Guide to Best Practice, Second, Completely Revised and Updated Edition

    Phil Nethercote, Joachim Ermer, Pages: 1–10, 2014

    Published Online : 15 AUG 2014, DOI: 10.1002/9783527672202.ch1

  11. A Systematic Approach to Impurity Identification

    Analysis of Drug Impurities

    Richard J. Smith, Michael L. Webb, Pages: 124–155, 2007

    Published Online : 12 NOV 2007, DOI: 10.1002/9780470988749.ch5

  12. Characterization and First Principles Prediction of API Reaction Systems

    Chemical Engineering in the Pharmaceutical Industry: R&D to Manufacturing

    David J. am Ende, Pages: 113–136, 2010

    Published Online : 29 OCT 2010, DOI: 10.1002/9780470882221.ch9

  13. Integrated Assessment and Clinical Translation of In Vitro Off-Target Safety Pharmacology Risks

    Predictive ADMET: Integrative Approaches in Drug Discovery and Development

    Patrick Y. Muller, Christian F. Trendelenburg, Pages: 397–406, 2014

    Published Online : 7 MAR 2014, DOI: 10.1002/9781118783344.ch17

  14. Regulatory Aspects of Pharmacovigilance

    Stephens' Detection and Evaluation of Adverse Drug Reactions: Principles and Practice, Sixth Edition

    Kristina Leila Strutt, Barry David Charles Arnold, Pages: 411–509, 2012

    Published Online : 30 JAN 2012, DOI: 10.1002/9780470975053.ch8

  15. A double-blind comparative study of sertraline and amitriptyline in outpatients with major depressive episodes

    Human Psychopharmacology: Clinical and Experimental

    Volume 9, Issue 1, January/February 1994, Pages: 63–68, G. Bersani, V. Rapisarda, N. Ciani, A. Bertolino and G. Sorge

    Article first published online : 13 OCT 2004, DOI: 10.1002/hup.470090108

  16. Evolution and Integration of Quality by Design and Process Analytical Technology

    Quality by Design for Biopharmaceuticals: Principles and Case Studies

    Duncan Low, Joseph Phillips, Pages: 255–286, 2008

    Published Online : 28 OCT 2008, DOI: 10.1002/9780470466315.ch13

  17. Pharmacovigilance

    The Textbook of Pharmaceutical Medicine, 7th Edition

    Stephen F. Hobbiger, Bina Patel, Elizabeth Swain, Pages: 235–253, 2013

    Published Online : 25 APR 2013, DOI: 10.1002/9781118532331.ch11

  18. Quality Assurance Requirements in Plasma Product Manufacture

    Production of Plasma Proteins for Therapeutic Use

    Joseph Bertolini, Neil Goss, John Curling, Pages: 381–401, 2012

    Published Online : 14 DEC 2012, DOI: 10.1002/9781118356807.ch28

  19. Food and Drug Administration: Nonclinical Program and Pharmaceutical Approval

    Nonclinical Safety Assessment: A Guide to International Pharmaceutical Regulations

    William J. Brock, Kenneth L. Hastings, Pages: 27–39, 2013

    Published Online : 10 MAR 2013, DOI: 10.1002/9781118517000.ch3

  20. Pharmacovigilance Medical Writing in Risk Evaluation and Management

    Pharmacovigilance Medical Writing: A Good Practice Guide

    Justina Orleans-Lindsay, Pages: 75–115, 2012

    Published Online : 19 JUN 2012, DOI: 10.1002/9781118301906.ch4